No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AORT Artivion
- 23.120
- -0.180-0.77%
Close Jun 14 16:00 ET
- 23.120
- 0.0000.00%
Post 16:05 ET
964.90MMarket Cap-96333P/E (TTM)
23.150High22.560Low146.09KVolume23.010Open23.300Pre Close3.36MTurnover0.43%Turnover RatioLossP/E (Static)41.73MShares25.51452wk High3.27P/B795.66MFloat Cap12.15852wk Low--Dividend TTM34.41MShs Float42.745Historical High--Div YieldTTM2.53%Amplitude1.335Historical Low22.964Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | NYSE Order Imbalance 56169.0 Shares on Buy Side
Express News | NYSE Order Imbalance 55982.0 Shares on Buy Side
Artivion(AORT.US) Officer Sells US$29,275.13 in Common Stock
$Artivion(AORT.US)$ Officer Holloway Jean F sold 1,250 shares of common stock on May 10, 2024 at an average price of $23.4201 for a total value of $29,275.13.Source: Announcement What is statement of
Artivion(AORT.US) Officer Sells US$23,285.52 in Common Stock
$Artivion(AORT.US)$ Officer Holloway Jean F sold 979 shares of common stock on May 9, 2024 at an average price of $23.785 for a total value of $23,285.52.Source: Announcement What is statement of chan
Express News | NYSE Order Imbalance 92714.0 Shares on Buy Side
Artivion (NYSE:AORT) Shareholder Returns Have Been Respectable, Earning 62% in 1 Year
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can significantly boost your returns by picking above-average stocks. To wit, the Artivi
Comments
Artivion's management optimizes capital structure for a new phase of profitable growth. Strong conviction in business outlook, recent financial performance and clinical data readouts expected to deliver significant shareholder value.
Press Release: Artivion Obtains $350 Million in Senior Secured Credit FacilitiesArtivion's reinvestment has not significantly improved sales, resulting in a 52% decline in stock over the past five years. The market perspective shows skepticism, implying Artivion may not have substantial growth potential.
Gapping up
In reaction to earnings/guidance:
• $CalAmp(CAMP.US$ +0.6%
Other news:
• $Cano Health(CANO.US$ +6.1% ( $Humana(HUM.US$ in the running to acquire CANO according to WSJ)
• $Corcept Therapeutics(CORT.US$ +4.5% (extends deal with Optime Care to March 31 2024)
• $LPL Financial(LPLA.US$ +4.1% (reports monthly activity for August)
• $Dentsply Sirona(XRAY.US$ +3% (names new CFO)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US$ +2.9% (tr...
In reaction to earnings/guidance:
• $CalAmp(CAMP.US$ +0.6%
Other news:
• $Cano Health(CANO.US$ +6.1% ( $Humana(HUM.US$ in the running to acquire CANO according to WSJ)
• $Corcept Therapeutics(CORT.US$ +4.5% (extends deal with Optime Care to March 31 2024)
• $LPL Financial(LPLA.US$ +4.1% (reports monthly activity for August)
• $Dentsply Sirona(XRAY.US$ +3% (names new CFO)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US$ +2.9% (tr...
16
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg